BioAge Labs, Inc. Securities Fraud Class Action Lawsuit – Levi & Korsinsky Contact
BioAge Labs, Inc. is currently facing a securities fraud class action lawsuit, and shareholders are encouraged to contact Levi & Korsinsky before March 10, 2025 to discuss their options. The lawsuit alleges that BioAge Labs made false and misleading statements that led to financial harm for shareholders.
Investors who purchased BioAge Labs securities between May 26, 2022 and February 22, 2025 may be eligible to participate in the lawsuit. The allegations include that BioAge Labs made misleading statements about their business prospects and the efficacy of their products, which artificially inflated the company’s stock price.
If you believe you were affected by these alleged actions, it’s important to reach out to Levi & Korsinsky before the deadline to explore your legal options. The class action lawsuit is currently pending, and shareholders have the opportunity to potentially recover financial losses resulting from the alleged securities fraud.
It’s crucial for investors to stay informed about legal proceedings like this class action lawsuit against BioAge Labs. By reaching out to Levi & Korsinsky, shareholders can get the guidance they need to understand their rights and potential next steps in seeking recourse for any financial harm they may have experienced.
